LTUS Stock Overview
Lotus Pharmaceuticals, Inc. does not have significant operations.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Lotus Pharmaceuticals, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.007 |
| 52 Week High | US$0.012 |
| 52 Week Low | US$0.0035 |
| Beta | 0 |
| 1 Month Change | 75.00% |
| 3 Month Change | n/a |
| 1 Year Change | -36.36% |
| 3 Year Change | -81.23% |
| 5 Year Change | -20.09% |
| Change since IPO | -99.91% |
Recent News & Updates
Recent updates
Shareholder Returns
| LTUS | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | 0% | -1.5% | -3.2% |
| 1Y | -36.4% | 9.7% | 19.3% |
Return vs Industry: LTUS underperformed the US Pharmaceuticals industry which returned 9.7% over the past year.
Return vs Market: LTUS underperformed the US Market which returned 19.3% over the past year.
Price Volatility
| LTUS volatility | |
|---|---|
| LTUS Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 9.8% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.5% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: LTUS's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine LTUS's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | Zhong Yi Liu | lotuspharmaceuticalsusa.com |
Lotus Pharmaceuticals, Inc. does not have significant operations. Previously, it was engaged in the development, manufacture, and sale of pharmaceuticals in the People’s Republic of China. The company is based in Nashville, Tennessee.
Lotus Pharmaceuticals, Inc. Fundamentals Summary
| LTUS fundamental statistics | |
|---|---|
| Market cap | US$20.61m |
| Earnings (TTM) | US$1.72m |
| Revenue (TTM) | US$71.39m |
0.0x
P/E Ratio0.0x
P/S RatioIs LTUS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| LTUS income statement (TTM) | |
|---|---|
| Revenue | US$71.39m |
| Cost of Revenue | US$45.94m |
| Gross Profit | US$25.45m |
| Other Expenses | US$23.73m |
| Earnings | US$1.72m |
Last Reported Earnings
Sep 30, 2011
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did LTUS perform over the long term?
See historical performance and comparison